# Gamida Cell Ltd.

Gamida Cell Ltd. is a company headquartered in Jerusalem, Israel.

## Company overview

- **Legal name:** Gamida Cell Ltd.
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Jerusalem, Israel
- **Incorporated in:** L3
- **Fiscal year end:** December 31
- **SEC CIK:** 0001600847

## About

Gamida Cell Ltd. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001600847, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2024-03-27, it reported annual revenue of USD 1,784,000; net income of USD -62,996,000; total assets of USD 102,186,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $1.8M (USD 1,784,000)
- **Net income:** -$63.0M (USD -62,996,000)
- **Total assets:** $102.2M (USD 102,186,000)
- **Cash and equivalents:** $46.6M (USD 46,554,000)
- **Operating cash flow:** -$79.1M (USD -79,120,000)

### FY2022 (period ended 2022-12-31)

- **Net income:** -$79.4M (USD -79,375,000)
- **Total assets:** $124.8M (USD 124,773,000)
- **Cash and equivalents:** $64.7M (USD 64,657,000)
- **Operating cash flow:** -$70.4M (USD -70,423,000)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$89.8M (USD -89,793,000)
- **Total assets:** $148.8M (USD 148,786,000)
- **Cash and equivalents:** $55.9M (USD 55,892,000)
- **Operating cash flow:** -$81.8M (USD -81,760,000)

### FY2020 (period ended 2020-12-31)

- **Net income:** -$72.7M (USD -72,704,000)
- **Total assets:** $155.5M (USD 155,483,000)
- **Cash and equivalents:** $127.2M (USD 127,170,000)
- **Operating cash flow:** -$48.6M (USD -48,627,000)

## Recent SEC filings

- Form 8-K — filed 2024-05-24 — period 2024-05-24 — CURRENT REPORT
- Form 10-Q — filed 2024-05-23 — period 2024-03-31 — QUARTERLY REPORT
- Form 8-K — filed 2024-04-22 — period 2024-04-22 — CURRENT REPORT
- Form 10-K — filed 2024-03-27 — period 2023-12-31 — ANNUAL REPORT
- Form 8-K — filed 2024-03-27 — period 2024-03-26 — CURRENT REPORT
- Form 8-K — filed 2024-03-15 — period 2024-03-12 — CURRENT REPORT
- Form SC 13G — filed 2024-02-08
- Form 8-K — filed 2024-01-29 — period 2024-01-29 — CURRENT REPORT
- Form 8-K — filed 2024-01-08 — period 2024-01-08 — CURRENT REPORT
- Form 8-K — filed 2023-12-18 — period 2023-12-14 — CURRENT REPORT
- Form 8-K — filed 2023-11-24 — period 2023-11-20 — CURRENT REPORT
- Form 8-K — filed 2023-11-15 — period 2023-11-14 — CURRENT REPORT

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/gamida-cell-ltd

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology